Kusunoki M, Sato D, Nakamura T, Oshida Y, Tsutsui H, Natsume Y, Tsutsumi K, Miyata T
Moreover, clinical trials with the GLP-1 analogues liraglutide (Liraglutide Effect and Action in DiabetesEvaluation of Cardiovascular Outcome Results [LEADER]) and semaglutide (Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes [SUSTAIN6]) also showed a significant reduction in cardiovascular events [13, 14]
However, its always wise to monitor liver health when introducing any new compound into your regimen
For diabetes management, the higher doses tend to provide better blood sugar control, but your healthcare provider will determine the best dose for your needs
You're struggling with weight loss or maintaining muscle mass
Neuroprotection against neuroblastoma cell death induced by depletion of mitochondrial glutathione